Galisteo Myriam Gallego, Puerto Javier Romero, Bautista Maria José Martínez, Navarro Jorge Díaz, Elcuaz Rosa Seisdedos, Galisteo Juan Gallego, Rubio Alberto Villa, de Juan María Del Carmen Jiménez, Andrades Ana Ganfornina, Cantero Marcelo Domínguez, Morales José Carlos Roldán, Ramos Jaime Cordero, García Alfonso Sánchez, Ortiz Carlos Núñez, Álvarez José Ramón Ávila
Pharmacy, Hospital de la Línea (Pharmacy Service) Ronda Norte Esq Gabriel Miro, s/n, La Línea de la Concepción, 11300 Cádiz, Spain.
Pharmacy, Hospital Universitario Virgen del Rocío, Sevilla, Spain.
Drugs Ther Perspect. 2022;38(9):406-415. doi: 10.1007/s40267-022-00943-5. Epub 2022 Sep 2.
Due to their impact on healthcare systems, the sustainability and optimization of high-cost drugs is an issue of concern for several countries. Different strategies have been implemented such as centralized purchasing to optimize budgetary resources. However, there is still a need for a mechanism to optimize these drugs further.
We conducted this prospective multicenter intervention study in five hospitals in the Andalusian Public Health System of Cádiz (Spain) between July 2019 and September 2021. We developed an online website (Farmastock) and implemented it to determine the availability of high-cost, low-use, and near-expiry medicines in each hospital. We used a simple analysis using operational variables to assess the project intervention's savings impact on managing these high-cost drugs.
The implementation of Farmastock in Cádiz resulted in savings of 675,757.52 € for the Andalusian Public Health System, with 238 medicines transferred out of the 373 available. Of these medicines offered, the most considerable percentage were medicines used for pathologies with high clinical instability and accounted for nearly 80% of the medicines optimized by the tool.
Farmastock allowed the Andalusian Public Health System to make substantial financial savings by not making new purchases of high-cost drugs available in other centers of this health network that were not being used. Therefore, this tool is a very efficient measure to contribute to the sustainability of the APHS and could be implemented in more hospitals soon.
由于其对医疗系统的影响,高成本药物的可持续性和优化是多个国家关注的问题。已经实施了不同的策略,如集中采购以优化预算资源。然而,仍需要一种机制来进一步优化这些药物。
2019年7月至2021年9月期间,我们在西班牙加的斯安达卢西亚公共卫生系统的五家医院进行了这项前瞻性多中心干预研究。我们开发了一个在线网站(Farmastock)并实施它,以确定每家医院中高成本、低使用量和接近过期药品的可用性。我们使用操作变量进行简单分析,以评估项目干预对管理这些高成本药物的节省影响。
在加的斯实施Farmastock为安达卢西亚公共卫生系统节省了675,757.52欧元,在373种可用药品中有238种被调出。在提供的这些药品中,最大比例的是用于临床不稳定程度高的病症的药品,占该工具优化药品的近80%。
Farmastock使安达卢西亚公共卫生系统通过不采购该卫生网络其他中心未使用的高成本新药而实现了大量财务节省。因此,该工具是有助于安达卢西亚公共卫生系统可持续性的一项非常有效的措施,并且可能很快会在更多医院实施。